share_log

Stifel Maintains Buy on Precigen, Raises Price Target to $10

Benzinga ·  Jun 4 00:20

Stifel analyst Benjamin Burnett maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $7 to $10.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment